Drug Research
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
Amgen announced that it has won the Best New Drug awardfor Prolia(TM) (denosumab), a novel treatment approved in the United States (U.S.)...
Clinical Trials
Sanofi Pasteur’s Dengue Vaccine in Final Stage of Clinical Development
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that its dengue vaccine is in final stage of clinical development. Sanofi Pasteur’s dengue vaccine,...
News
Eli Lilly and Company received FDA approval for Cymbalta
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of chronic musculoskeletal...
Research Insight
New data show potential for Novartis Meningitis B vaccine candidate to cover majority of diverse meningococcal serogroup B strains
New data demonstrated that antibodies induced by Novartis Vaccines investigational, four component, Meningococcal Serogroup B Vaccine (4CMenB) killed the majority of a collection of...
Clinical Trials
Roche reports promising Phase II results with new targeted approach in advanced melanoma
Roche announced results from a Phase II clinical study of RG7204 PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form...
Industry Reports
BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
BioMimetic Therapeutics, Inc. reported its financial results as of and for the three and nine months ended September 30, 2010. For the three months...
Production & Manufacturing
Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma
Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
